0001179110-20-007493.txt : 20200617
0001179110-20-007493.hdr.sgml : 20200617
20200617160943
ACCESSION NUMBER: 0001179110-20-007493
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200615
FILED AS OF DATE: 20200617
DATE AS OF CHANGE: 20200617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vandervoort Adam C
CENTRAL INDEX KEY: 0001375088
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 20969823
MAIL ADDRESS:
STREET 1: 485 MADISON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
edgar.xml
FORM 4 -
X0306
4
2020-06-15
0
0001477449
Teladoc Health, Inc.
TDOC
0001375088
Vandervoort Adam C
C/O TELADOC HEALTH, INC.,
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
0
1
0
0
Chief Legal Officer, Secretary
Common Stock
2020-06-15
4
M
0
1136
A
1336
D
Common Stock
2020-06-15
4
S
0
547
175.57
D
789
D
Common Stock
2020-06-16
4
S
0
589
184.81
D
200
D
Restricted Stock Units
2020-06-15
4
M
0
1136
0.00
D
Common Stock
1136
1136
D
Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.
Restricted stock units convert to common stock on a one-for-one basis.
On June 14, 2017, the reporting person was was granted 4,545 restricted stock units, vesting in four equal annual installments beginning on June 14, 2018.
Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 16, 2020.
/s/ Adam C. Vandervoort
2020-06-16